ULB, CHU Saint-Pierre, Hôpital Erasme, ULiège - FNRS

" The project investigates the immune responses to SARS-CoV-2 infection in humans. Cohorts of patients and contacts are recruited and followed-up during several months following infection. Using systems serology and systems biology approaches, the quality and dynamics of antibody and cellular responses are analysed to identify correlates of protection against severe disease and to determine the duration of natural immunity to the virus. The project should provide insight in the host response to SARS-CoV-2 and should help define deconfinement strategies and develop prophylactic and therapeutic interventions against COVID-19. "
Funding: COVID 19 - ULB
Contact: Arnaud Marchant: This email address is being protected from spambots. You need JavaScript enabled to view it. Stanislas Goriely: This email address is being protected from spambots. You need JavaScript enabled to view it.

Tests &Diagnostics covid-19
" The veterinary laboratories from Sciensano use their expertise, their equipment and their reagents to increase the testing capacity for Covid-19 in collaboration with IBC LAB (Institute of Clinical Biology of ULB). They optimized the extraction method and the CDC RT-PCR method and are able to rapidly adapt any change in the field situation. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

UMONS, ULB, Sciensano
" A new type of biosensor to characterize in details antibodies specific for antigens of SARS-COV-2. "
Funding: UMONS
Publication References: E. Gosselin, O Denis, A. Van Cauwenberge, J. Conti, JJ Vanden Eynde, K. Huygen, J. De Coninck, "Quantification of the trichothecene Verrucarin-A in environmental samples using an antibody-based spectroscopic biosensor", Sensor Actuat. B.-Chem., 2012, 166-167, 549-555.
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

ULB and Sciensano - FNRS
" La spectroscopie IR fournit des signatures spectroscopiques spécifiques permettant une détection rapide de biomolécules dans un échantillon complexe, tout en ne requérant que très peu de matériel. La création d'un biosenseur basé sur cette méthode et appliqué aux anticorps contre le SARS-COV-2, permettrait d'étudier de manière beaucoup plus sensible, spécifique et quantitative les réponses immunologiques de la population contre le SARS-COV-2 que les tests sérologiques actuels. C'est un enjeu majeur pour gérer la période de déconfinement. "
Funding: Demande en attente auprès de l'AUF
Contact: Vincent Raussens Senior Research Associate (FRS-FNRS Belgium) Université libre de Bruxelles Structure and Function of Biological Membranes bd. du Triomphe, Access 2 - 1050 Brussels, Belgium T : +32 (0)2 650 53 86 This email address is being protected from spambots. You need JavaScript enabled to view it.